Merck CEO Who Developed Ebola Vaccine Talks Covid-19 (Correct)

For nearly six months, U.S. drug giant Merck & Co. led a quiet effort to reach deals and secure federal funding to develop vaccines against the deadly coronavirus.

Top U.S. health leaders hinted that Merck, a drugmaker known for its nearly 130-year legacy of developing vaccines,had something brewing. On Tuesday, Chief Executive Officer Kenneth Frazier broke his silence, revealing a multi-pronged approach to tackling the pandemic.

Kenneth Frazier

Photographer: Chris Goodney/Bloomberg

The 65-year-old lawyer-turned-CEO has built up Merck’s oncology franchise while committing capital to less lucrative inoculations and antivirals critical to global public health. In December, he heralded the first-ever Ebola ...